PAVM - PAVmed Subsidiary Veris Health Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute | Benzinga
Parties to implement a pilot program of the Veris Cancer Care Platform
NEW YORK, April 30, 2024 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. ("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (the "OSUCCC – James"), a National Cancer Institute-Designated Comprehensive Cancer Center, have executed a memorandum of understanding to implement a pilot program where cancer patients would be enrolled on the Veris Cancer Care Platform™.
"The OSUCCC – James is one of the largest and most prestigious academic cancer centers in the nation and we couldn't be more excited to work with such a renowned institution at the forefront of cancer care during the pilot program," said Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer and Veris' Executive Chairman.
"Our vision is to enhance personalized cancer care through the use of cutting-edge digital health tools," said Gary K. Manning, Veris' President. "We look forward to completing a successful pilot program and to offering enhanced personalized cancer care to the thousands of patients who receive systemic cancer therapy there every year."
"At the OSUCCC – James, personalized, compassionate cancer care is at the core of what we do. Remote monitoring allows for the integration of expert, sub-specialized oncology care in a patient's own home, surrounded by their support system. This component of the cancer care continuum is yet another way we are engaging in the future of cancer care and is in line with our pursuit of a cancer-free world," said David Cohn, M.D., M.B.A., interim chief executive officer and chief medical officer at The James Cancer Hospital and Solove Research Institute.
The Veris Cancer Care Platform is a comprehensive digital cancer care platform with remote physiological data collection, symptom reporting, telehealth capability, and ...